FANGZHOU JIANKE has reached a strategic partnership with INNOVENT BIO

AASTOCKS
2025.09.14 12:13

FANGZHOU JIANKE (06086.HK) announced in a press release published at the 10th H2H Healthcare Services Ecosystem Conference held on September 10, the latest news from the company, including the launch of its proprietary "XingShi" large model as the cornerstone of its five flagship applications (AI Medication Assistant, AI Health Steward, AI Doctor Assistant, AI Academic Assistant, and AI Search), empowering advanced clinical diagnostic support and personalized chronic disease management; establishing a strategic partnership with INNOVENT BIO to integrate the FANGZHOU H2H digital health ecosystem with INNOVENT's weight management therapy pipeline, initially utilizing the company's XingShi large model to provide personalized digital maintenance and compliance support for INNOVENT's MaShidu peptide, enhancing patient efficacy in China's rapidly growing weight management market; and engaging in a strategic collaboration with Zhejiang Otsuka Pharmaceutical to jointly develop comprehensive digital solutions covering medication support services, targeted patient outreach programs, and health education initiatives

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.